How to Fill Out and File a Depo-Provera Claim Form

To file a Depo-Provera claim, you retain a product liability attorney on contingency, who files a federal complaint on your behalf that is then transferred into the consolidated litigation known as MDL No. 3140, pending before Judge M. Casey Rodgers in the Northern District of Florida.1United States District Court. Depo-Provera Products Liability Litigation MDL No. 3140 Before that filing, you need to confirm you meet two thresholds — enough exposure to injectable medroxyprogesterone acetate and a confirmed meningioma diagnosis — and gather the medical, imaging, and pharmacy records that prove both.

Confirm You Meet the Basic Eligibility

Two things have to be true. First, you received Depo-Provera, Depo-subQ Provera 104, or an authorized generic equivalent for more than one year. Most legal teams look for at least two injections within a twelve-month window, since the drug is administered every three months. The 2024 study in the British Medical Journal found an odds ratio of 5.55 for intracranial meningioma among users of injectable medroxyprogesterone acetate, with the excess risk driven by prolonged use of a year or more.2The BMJ. Use of Progestogens and the Risk of Intracranial Meningioma: National Case-Control Study

Second, you have a meningioma diagnosis, located within the skull or along the spinal cord, confirmed by an MRI or CT scan. Claims do not qualify if the tumor was diagnosed before you ever received the injection. A tumor that appeared years after your last shot may still qualify if the duration of exposure was substantial enough to support the connection.

If You Only Used a Generic Version

The MDL covers both Pfizer’s brand-name Depo-Provera and generic equivalents containing medroxyprogesterone acetate.1United States District Court. Depo-Provera Products Liability Litigation MDL No. 3140 Suing a generic manufacturer for failure to warn is harder, however. The Supreme Court held in PLIVA, Inc. v. Mensing that generic drug makers must copy the brand-name label and cannot independently change it, which means state-law failure-to-warn claims against them may be preempted.3Justia Law. PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011) The MDL court is briefing the preemption issue as it applies to these cases, so whether generic-only users can recover is unsettled. Raise it with an attorney early if it applies to you.

Gather Your Records Before You Call an Attorney

Your paperwork is the foundation of the claim, and organizing it before you meet with counsel saves weeks of chasing.

Start with the medical records from every clinic, doctor’s office, or reproductive health provider who administered the shots. Those records should show the dates of each injection and the dosage. If you reported side effects at any visit, the chart notes from those appointments strengthen the timeline. Gaps in the record give the defense room to argue that your exposure was shorter than you claim.

For the tumor itself, pull copies of imaging reports (MRI or CT) along with any pathology reports if a biopsy or surgery was performed. The radiology report should describe the location and size of the meningioma. If you had surgery, get the operative report and post-surgical follow-up records documenting complications or ongoing neurological monitoring.

Pharmacy records and insurance Explanation of Benefits statements back up the clinical file. They create a financial paper trail that matches, or fills gaps in, the provider records. If your clinic has closed or your chart is incomplete, pharmacy and insurance data may be the only proof of certain injection dates. Where possible, note the National Drug Code or lot numbers on pharmacy records so your specific injections can be tied to a particular manufacturer.

The Plaintiff Fact Sheet

Once your case is filed, you will need to complete a Plaintiff Fact Sheet, a standardized questionnaire the MDL court uses to gather essential details from every plaintiff. Fact sheets in pharmaceutical MDLs typically ask for the dates of your first and last use of the drug, the names of every healthcare provider who prescribed or administered it, and your full medical history related to the diagnosis. Organizing your records chronologically before your attorney prepares the fact sheet saves time and reduces errors.

How the Filing Actually Happens

You do not file directly into the MDL. Your attorney files a complaint in a federal district court, typically the one where you live or where the injury occurred, and the Judicial Panel on Multidistrict Litigation transfers it into MDL No. 3140 in the Northern District of Florida for pretrial proceedings.1United States District Court. Depo-Provera Products Liability Litigation MDL No. 3140 From there, Judge Rodgers oversees discovery, expert witness challenges, and pretrial motions for every case in the consolidated docket.

After filing, you go through a threshold proof-of-use-and-injury process, essentially a preliminary check that your claim meets the basic eligibility requirements before it advances. The defendant then responds to the complaint, typically within 30 days, often with motions to dismiss or affirmative defenses. Both sides exchange information through discovery: your medical and pharmacy records, the manufacturer’s internal documents about what it knew about meningioma risk, and expert reports on causation.

A Plaintiffs’ Steering Committee appointed by the court coordinates strategy across all cases so individual attorneys don’t duplicate work on shared issues. The first bellwether trial in the MDL is scheduled for December 2026.1United States District Court. Depo-Provera Products Liability Litigation MDL No. 3140

Watch the Filing Deadline

Every state sets its own statute of limitations for personal injury claims, typically ranging from one to four years. Miss the deadline and you lose your right to sue, no matter how strong your evidence is.

The critical question is when the clock starts. Under the discovery rule, the limitations period does not begin until you knew or reasonably should have known that your injury was connected to the drug. The major research linking injectable medroxyprogesterone acetate to meningioma was not published until 2024, and the FDA did not add a meningioma warning to the Depo-Provera CI and Depo-subQ Provera 104 label until December 2025.4U.S. Food and Drug Administration. Depo-Provera CI and Depo-subQ Provera 104 Prescribing Information For women whose injections or diagnosis go back years, the filing clock may have only recently started.

The rule does not run forever, though. Once you have enough information to reasonably suspect a connection, whether from news coverage, a doctor’s comment, or the label change itself, the clock begins and the deadline is firm. States apply the rule differently. New York limits it in product liability cases; California is more generous. Contact an attorney promptly rather than assuming you have unlimited time.

What You’ll Pay and What Comes Out of a Recovery

Depo-Provera cases are handled on contingency, so you pay nothing upfront. Your attorney collects a percentage of your settlement or verdict only if you win. Contingency fees in mass tort pharmaceutical cases typically fall between 25 and 40 percent of the recovery, depending on complexity and the stage at which the case resolves. Get the exact percentage in writing before you sign the retainer, and ask whether litigation costs (filing fees, expert witness fees, medical record retrieval) are deducted before or after the contingency percentage is calculated. The order of those deductions changes your net recovery.

The MDL court also establishes a common benefit fund to compensate Steering Committee attorneys for shared work. This fund is typically financed by a small assessment on each plaintiff’s settlement, often around one to two percent, and may also come from a reduction in individual attorneys’ fees. These deductions are court-ordered and mandatory.

Medicare, Medicaid, and Insurer Liens

If Medicare or Medicaid paid for any of your meningioma treatment, those programs have a legal right to be reimbursed from your settlement. Under the Medicare Secondary Payer Act, Medicare can recover medical expenses it covered that are attributable to the injury.5Office of the Law Revision Counsel. 42 U.S. Code 1395y – Exclusions From Coverage and Medicare as Secondary Payer State Medicaid programs have parallel recovery rights. These liens apply only to the portion of your settlement allocated to medical expenses; funds designated for lost wages or pain and suffering are generally protected.

Before your check is cut, your attorney should obtain a conditional payment letter from Medicare, if applicable, showing what Medicare paid and expects back. You can dispute charges on that letter if some listed treatments were unrelated to your meningioma. Medicaid liens can sometimes be negotiated down, particularly where full reimbursement would leave you unable to cover future care. Private health insurers may also assert subrogation rights. Resolving all liens before distribution is essential; failing to reimburse Medicare can expose both you and the settling defendant to penalties, including double damages.

What Damages the Claim Can Cover

Successful claims seek compensation across several categories, and the total depends on how severe your medical situation became.

  • Past and future medical expenses, including neurosurgery, hospital stays, radiation, rehabilitation, prescription medications, and long-term surveillance imaging.
  • Lost income during treatment and recovery, plus future earning capacity if the tumor or its treatment left you unable to work at your prior level.
  • Pain and suffering, covering the physical and emotional toll of a brain tumor diagnosis, surgery, recovery, and anxiety about recurrence.

Some jurisdictions allow punitive damages when a manufacturer’s conduct goes beyond ordinary negligence, for example if evidence shows the company knew about the meningioma risk and concealed it. Availability depends on the law of the state where your case was filed, and punitive damages require a higher burden of proof than compensatory claims. Some states also recognize medical monitoring as a standalone basis for recovery for people exposed to a serious health risk; others require a present physical injury first. Either way, ongoing imaging costs can be folded into your broader damages calculation if you have a diagnosed meningioma.